Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
6.01
+0.07 (1.18%)
At close: Apr 1, 2025, 4:00 PM
6.02
+0.01 (0.18%)
After-hours: Apr 1, 2025, 4:07 PM EDT

Atara Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
25.0325.8492.94106.08200.4
Upgrade
Short-Term Investments
17.4725.88149.88264.98300.26
Upgrade
Cash & Short-Term Investments
42.551.73242.82371.07500.66
Upgrade
Cash Growth
-17.84%-78.70%-34.56%-25.88%93.22%
Upgrade
Accounts Receivable
1.4834.1140.220.99-
Upgrade
Other Receivables
--0.80.81.95
Upgrade
Receivables
1.4834.1141.021.791.95
Upgrade
Inventory
10.669.711.59--
Upgrade
Prepaid Expenses
----20.47
Upgrade
Restricted Cash
0.150.150.150.190.19
Upgrade
Other Current Assets
10.126.189.5111.57-
Upgrade
Total Current Assets
64.89101.87295.08384.62523.27
Upgrade
Property, Plant & Equipment
41.158.7974.3279.9462.82
Upgrade
Other Long-Term Assets
3.14.847.023.572.03
Upgrade
Total Assets
109.1165.5376.42468.13588.12
Upgrade
Accounts Payable
4.373.686.8717.377.12
Upgrade
Accrued Expenses
21.248.5350.4144.9140.34
Upgrade
Current Portion of Leases
13.9212.1813.642.751.99
Upgrade
Current Unearned Revenue
95.0977.83840.7633.46
Upgrade
Total Current Liabilities
134.57142.2378.92105.7982.9
Upgrade
Long-Term Leases
31.5245.6958.0625.5213.04
Upgrade
Long-Term Unearned Revenue
38.6272.19107.2455.7127.8
Upgrade
Other Long-Term Liabilities
1.674.635.561.52.04
Upgrade
Total Liabilities
206.38264.74249.78188.51125.78
Upgrade
Common Stock
0-0.010.010.01
Upgrade
Additional Paid-In Capital
1,9571,8701,8221,7451,587
Upgrade
Retained Earnings
-2,055-1,969-1,693-1,465-1,125
Upgrade
Comprehensive Income & Other
0.01-0.2-2.07-0.370.3
Upgrade
Shareholders' Equity
-97.28-99.23126.64279.61462.34
Upgrade
Total Liabilities & Equity
109.1165.5376.42468.13588.12
Upgrade
Total Debt
45.4357.8771.728.2715.03
Upgrade
Net Cash (Debt)
-2.94-6.15171.12342.8485.63
Upgrade
Net Cash Growth
---50.08%-29.41%99.53%
Upgrade
Net Cash Per Share
-0.39-1.4541.9491.49164.13
Upgrade
Filing Date Shares Outstanding
5.864.773.843.723.34
Upgrade
Total Common Shares Outstanding
5.864.263.843.673.33
Upgrade
Working Capital
-69.68-40.36216.16278.84440.37
Upgrade
Book Value Per Share
-16.60-23.3133.0076.25138.64
Upgrade
Tangible Book Value
-97.28-99.23126.64279.61462.34
Upgrade
Tangible Book Value Per Share
-16.60-23.3133.0076.25138.64
Upgrade
Machinery
17.6718.6617.8226.0519.18
Upgrade
Construction In Progress
-0.160.036.330.88
Upgrade
Leasehold Improvements
0.930.90.8850.1450.13
Upgrade
Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q